2025 United Kingdom Automatic Nucleic Acid Extraction Instrument Market Revenue Opportunities Report
Description
The 2025 United Kingdom Automatic Nucleic Acid Extraction Instrument Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Automatic Nucleic Acid Extraction Instrument Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Automatic Nucleic Acid Extraction Instrument Market in the United Kingdom include PerkinElmer Inc., ACON Laboratories, Labtron Equipment Ltd., and Qiagen. PerkinElmer, founded in 1937, specializes in laboratory technologies including nucleic acid extraction systems applied broadly in biopharmaceuticals and diagnostics. ACON Laboratories, based in San Diego, supplies diagnostic devices including nucleic acid extraction systems for clinical and veterinary applications. Labtron Equipment Ltd., headquartered in Surrey, UK, offers compact automated nucleic acid extraction systems with versatile magnetic bead technology for DNA and RNA isolation suited for diagnostics and research labs. Qiagen operates the QiaSymphony automated extraction platform at the Jenner Institute in Oxford, supporting high-throughput, high-quality extraction used globally in research and diagnostics with minimal contamination and hands-on time.
These companies provide systems employing magnetic bead or silica membrane technology to automate DNA and RNA isolation from various samples including blood, tissues, and viruses. Their instruments enhance sample throughput, purity, and reproducibility essential for downstream molecular and genomic analyses. While PerkinElmer and ACON have broader diagnostic portfolios with nucleic acid extraction as a part, Labtron and Qiagen deliver focused nucleic acid extraction systems optimized for the UK market. Qiagen’s QiaSymphony notably supports large scale clinical trials and collaborations within UK research institutions. This competitive landscape reflects the integration of automated extraction instruments into precision diagnostic and research workflows in the UK.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Automatic Nucleic Acid Extraction Instrument Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Automatic Nucleic Acid Extraction Instrument Market in the United Kingdom include PerkinElmer Inc., ACON Laboratories, Labtron Equipment Ltd., and Qiagen. PerkinElmer, founded in 1937, specializes in laboratory technologies including nucleic acid extraction systems applied broadly in biopharmaceuticals and diagnostics. ACON Laboratories, based in San Diego, supplies diagnostic devices including nucleic acid extraction systems for clinical and veterinary applications. Labtron Equipment Ltd., headquartered in Surrey, UK, offers compact automated nucleic acid extraction systems with versatile magnetic bead technology for DNA and RNA isolation suited for diagnostics and research labs. Qiagen operates the QiaSymphony automated extraction platform at the Jenner Institute in Oxford, supporting high-throughput, high-quality extraction used globally in research and diagnostics with minimal contamination and hands-on time.
These companies provide systems employing magnetic bead or silica membrane technology to automate DNA and RNA isolation from various samples including blood, tissues, and viruses. Their instruments enhance sample throughput, purity, and reproducibility essential for downstream molecular and genomic analyses. While PerkinElmer and ACON have broader diagnostic portfolios with nucleic acid extraction as a part, Labtron and Qiagen deliver focused nucleic acid extraction systems optimized for the UK market. Qiagen’s QiaSymphony notably supports large scale clinical trials and collaborations within UK research institutions. This competitive landscape reflects the integration of automated extraction instruments into precision diagnostic and research workflows in the UK.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
